TY - JOUR
T1 - Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations
AU - Vilaró, Jordi
AU - Ramirez-Sarmiento, Alba
AU - Martínez-Llorens, Juana Ma
AU - Mendoza, Teresa
AU - Alvarez, Miguel
AU - Sánchez-Cayado, Natalia
AU - Vega, Ángeles
AU - Gimeno, Elena
AU - Coronell, Carlos
AU - Gea, Joaquim
AU - Roca, Josep
AU - Orozco-Levi, Mauricio
N1 - Funding Information:
Sources of support : Supported in part by grants from “ SEPAR-Area de Enfermería y Fisioterapia ” and BAE06/90061 . CIBERES (Instituto de Salud Carlos III, Ministerio de Sanidad, Spain).
PY - 2010/12
Y1 - 2010/12
N2 - Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with several modifiable (sedentary life-style, smoking, malnutrition, hypoxemia) and non-modifiable (age, co-morbidities, severity of pulmonary function, respiratory infections) risk factors. We hypothesise that most of these risk factors may have a converging and deleterious effects on both respiratory and peripheral muscle function in COPD patients. Methods: A multicentre study was carried out in 121 COPD patients (92% males, 63 ± 11 yr, FEV1, 49 ± 17%pred). Assessments included anthropometrics, lung function, body composition using bioelectrical impedance analysis (BIA), and global muscle function (peripheral muscle (dominant and non-dominant hand grip strength, HGS), inspiratory (PImax), and expiratory (PEmax) muscle strength). GOLD stage, clinical status (stable vs. non-stable) and both current and past hospital admissions due to COPD exacerbations were included as covariates in the analyses. Results: Respiratory and peripheral muscle weakness were observed in all subsets of patients. Muscle weakness, was significantly associated with both current and past hospitalisations. Patients with history of multiple admissions showed increased global muscle weakness after adjusting by FEV1 (PE max, OR = 6.8, p < 0.01; PImax, OR = 2.9, p < 0.05; HGSd, OR = 2.4, and HGSnd, OR = 2.6, p = 0.05). Moreover, a significant increase in both respiratory and peripheral muscle weakness, after adjusting by FEV 1, was associated with current acute exacerbations. Conclusions: Muscle dysfunction, adjusted by GOLD stage, is associated with an increased risk of hospital admissions due to acute episodes of exacerbation of the disease. Current exacerbations further deteriorate muscle dysfunction.
AB - Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with several modifiable (sedentary life-style, smoking, malnutrition, hypoxemia) and non-modifiable (age, co-morbidities, severity of pulmonary function, respiratory infections) risk factors. We hypothesise that most of these risk factors may have a converging and deleterious effects on both respiratory and peripheral muscle function in COPD patients. Methods: A multicentre study was carried out in 121 COPD patients (92% males, 63 ± 11 yr, FEV1, 49 ± 17%pred). Assessments included anthropometrics, lung function, body composition using bioelectrical impedance analysis (BIA), and global muscle function (peripheral muscle (dominant and non-dominant hand grip strength, HGS), inspiratory (PImax), and expiratory (PEmax) muscle strength). GOLD stage, clinical status (stable vs. non-stable) and both current and past hospital admissions due to COPD exacerbations were included as covariates in the analyses. Results: Respiratory and peripheral muscle weakness were observed in all subsets of patients. Muscle weakness, was significantly associated with both current and past hospitalisations. Patients with history of multiple admissions showed increased global muscle weakness after adjusting by FEV1 (PE max, OR = 6.8, p < 0.01; PImax, OR = 2.9, p < 0.05; HGSd, OR = 2.4, and HGSnd, OR = 2.6, p = 0.05). Moreover, a significant increase in both respiratory and peripheral muscle weakness, after adjusting by FEV 1, was associated with current acute exacerbations. Conclusions: Muscle dysfunction, adjusted by GOLD stage, is associated with an increased risk of hospital admissions due to acute episodes of exacerbation of the disease. Current exacerbations further deteriorate muscle dysfunction.
KW - Exacerbation
KW - Hospitalisation
KW - Muscle weakness
KW - Nutrition
KW - Respiratory and peripheral muscles
UR - http://www.scopus.com/inward/record.url?scp=78449249653&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2010.05.001
DO - 10.1016/j.rmed.2010.05.001
M3 - Article
AN - SCOPUS:78449249653
SN - 0954-6111
VL - 104
SP - 1896
EP - 1902
JO - Respiratory Medicine
JF - Respiratory Medicine
IS - 12
ER -